Body Composition and the Components of Metabolic Syndrome in Type 2 Diabetes: The Roles of Disease Duration and Glycemic Control

References

• American Diabetes A. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–S28. doi:10.2337/dc19-S002
   PubMedGoogle Scholar
• International Diabetes Federation. Chapter 1: What is diabetes? In: Karuranga S, Fernandes JDR, Huang Y, Malanda B, editors. Diabetes Atlas Eighth edition 2017. 2017:1–150.
   Google Scholar
• Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51–60. doi:10.1038/s41586-019-1797-8
   PubMed Web of Science ®Google Scholar
• Arneth B, Arneth R, Shams M. Metabolomics of type 1 and type 2 diabetes. Int J Mol Sci. 2019;20(10):2467. doi:10.3390/ijms20102467
   PubMed Web of Science ®Google Scholar
• Kong AP, Luk AO, Chan JC. Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated? Best Pract Res Clin Endocrinol Metab. 2016;30(3):345–355. doi:10.1016/j.beem.2016.06.003
   PubMedGoogle Scholar
• Das SR, Everett BM, Birtcher KK, et al. 2018 ACC Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the american college of cardiology task force on expert consensus decision pathways. J Am Coll Cardiol. 2018;72(24):3200–3223. doi:10.1016/j.jacc.2018.09.020
   PubMed Web of Science ®Google Scholar
• Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459–2502. doi:10.1161/CIRCULATIONAHA.116.022194
   PubMed Web of Science ®Google Scholar
• Alaei Faradonbeh N, Nikaeen F, Akbari M, Almasi N, Vakhshoori M. Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein. ARYA Atheroscler. 2018;14(4):163–168. doi:10.22122/arya.v14i4.1685
   PubMedGoogle Scholar
• Sherling DH, Perumareddi P, Hennekens CH. Metabolic Syndrome. J Cardiovasc Pharmacol Ther. 2017;22(4):365–367. doi:10.1177/1074248416686187
   PubMed Web of Science ®Google Scholar
• Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1–23. doi:10.1016/j.ecl.2013.09.009
   PubMed Web of Science ®Google Scholar
• Papaetis GS, Panagiotou TN, Panagiotou TN. Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci. 2015;11(3):463–482. doi:10.5114/aoms.2015.52350
   PubMed Web of Science ®Google Scholar
• Gupta P, Lanca C, Gan ATL, et al. The association between body composition using dual energy X-ray absorptiometry and type-2 diabetes: a systematic review and meta-analysis of observational studies. Sci Rep. 2019;9(1):12634. doi:10.1038/s41598-019-49162-5
   PubMedGoogle Scholar
• Wells JCK. Body composition and susceptibility to type 2 diabetes: an evolutionary perspective. Eur J Clin Nutr. 2017;71(7):881–889. doi:10.1038/ejcn.2017.31
   PubMedGoogle Scholar
• Jiang Y, Tan S, Wang Z, Guo Z, Li Q, Wang J. Aerobic exercise training at maximal fat oxidation intensity improves body composition, glycemic control, and physical capacity in older people with type 2 diabetes. J Exerc Sci Fit. 2020;18(1):7–13. doi:10.1016/j.jesf.2019.08.003
   PubMed Web of Science ®Google Scholar
• Ji M, Ren D, Dunbar-Jacob J, Gary-Webb TL, Erlen JA. Correlates of self-management behaviors, glycemic control and metabolic syndrome in patients with type 2 diabetes. Nurs Res. 2019.
   Web of Science ®Google Scholar
• Ravichandran S, Srivastav S, Kamble PH, et al. VEGF-A and cardiac autonomic function in newly diagnosed type 2 diabetes mellitus: a cross-sectional study at a tertiary care center. J Family Med Prim Care. 2019;8(10):3185–3190. doi:10.4103/jfmpc.jfmpc_537_19
   PubMedGoogle Scholar
• Ghouse J, Isaksen JL, Skov MW, et al. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes. Diabetes Obes Metab. 2019.
   PubMedGoogle Scholar
• Wysham CH, Pilon D, Ingham M, et al. HBA1C Control and cost-effectiveness in patients with type 2 diabetes mellitus initiated on canagliflozin or a glucagon-like peptide 1 receptor agonist in a real-world setting. Endocr Pract. 2018;24(3):273–287. doi:10.4158/EP-2017-0066
   PubMedGoogle Scholar
• Dean AG, Sullivan KM, Soe MM OpenEpi: open source epidemiologic statistics for public health, version; 2013. Available from: www.OpenEpi.com. Accessed December 21, 2019.
   Google Scholar
• Al-Rubeaan K, Bawazeer N, Al Farsi Y, et al. Prevalence of metabolic syndrome in Saudi Arabia - a cross sectional study. BMC Endocr Disord. 2018;18(1):16. doi:10.1186/s12902-018-0244-4
   PubMedGoogle Scholar
• Ghamri RA, Alamri SH. Metabolic syndrome among adults with type 2 diabetes in a Saudi teaching hospital: A comparative prevalence study using WHO and ATP III definitions. Pak J Med Sci. 2019;35(4):1087–1092. doi:10.12669/pjms.35.4.199
   PubMedGoogle Scholar
• Xiao J, Purcell SA, Prado CM, Gonzalez MC. Fat mass to fat-free mass ratio reference values from NHANES III using bioelectrical impedance analysis. Clin Nutr. 2018;37(6):2284–2287. doi:10.1016/j.clnu.2017.09.021
   PubMedGoogle Scholar
• Bakker AJ, Mucke M. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clin Chem Lab Med. 2007;45(9):1240–1243. doi:10.1515/CCLM.2007.254
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. doi:10.1056/NEJMoa0806470
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469–480. doi:10.1111/j.1464-5491.2006.01858.x
   PubMed Web of Science ®Google Scholar
• Janghorbani M, Amini M. Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran. ISRN Endocrinol. 2012;2012:8. doi:10.5402/2012/167318
   Google Scholar
• Jing Y, Hong T, Bi Y, et al. Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: china cardiometabolic registries 3B study. J Diabetes Investig. 2018;9(4):789–798. doi:10.1111/jdi.12785
   PubMed Web of Science ®Google Scholar
• Marott SC, Nordestgaard BG, Tybjaerg-Hansen A, Benn M. Components of the metabolic syndrome and risk of type 2 diabetes. J Clin Endocrinol Metab. 2016;101(8):3212–3221. doi:10.1210/jc.2015-3777
   PubMed Web of Science ®Google Scholar
• Meifang Y, Xue S, Jue H, et al. Metabolic syndrome increases Framingham risk score of patients with type 2 diabetes mellitus. Journal of Zhejiang University. Medical Sciences. 2016;45(3):268–274.
   Google Scholar
• Yang XY, Zhang M, Luo XP, et al. Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study. Zhonghua Yu Fang Yi Xue Za Zhi. 2016;50(4):328–333. doi:10.3760/cma.j.issn.0253-9624.2016.04.009
   PubMedGoogle Scholar
• Wang Q, Zheng D, Liu J, Fang L, Li Q. Skeletal muscle mass to visceral fat area ratio is an important determinant associated with type 2 diabetes and metabolic syndrome. Diabetes Metab Syndr Obes. 2019;12:1399–1407. doi:10.2147/DMSO.S211529
   PubMed Web of Science ®Google Scholar
• Solanki JD, Makwana AH, Mehta HB, Gokhale PA, Shah CJ. Body composition in type 2 diabetes: change in quality and not just quantity that matters. Int J Prev Med. 2015;6(1):122. doi:10.4103/2008-7802.172376.
   PubMedGoogle Scholar
• Gastaldelli A, Miyazaki Y, Pettiti M, et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab. 2002;87(11):5098–5103. doi:10.1210/jc.2002-020696
   PubMed Web of Science ®Google Scholar
• Kim K, Park SM. Association of muscle mass and fat mass with insulin resistance and the prevalence of metabolic syndrome in Korean adults: a cross-sectional study. Sci Rep. 2018;8(1):2703. doi:10.1038/s41598-018-21168-5
   PubMedGoogle Scholar
• Carrillo-Larco RM, Miranda JJ, Gilman RH, Checkley W, Smeeth L, Bernabe-Ortiz A. CRONICAS Cohort study group. the HOMA-IR performance to identify new diabetes cases by degree of urbanization and altitude in peru: the CRONICAS cohort study. J Diabetes Res. 2018;2018:8. doi:10.1155/2018/7434918
   Google Scholar
• Hernández-Alonso P, García-Gavilán J, Camacho-Barcia L, et al. Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation. Sci Rep. 2019;9(1):13895. doi:10.1038/s41598-019-50260-7.
   PubMedGoogle Scholar
• Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302. doi:10.1038/nrendo.2014.29
   PubMed Web of Science ®Google Scholar
• Ginsberg HN, Zhang YL, Hernandez-Ono A. Metabolic syndrome: focus on dyslipidemia. Obesity. 2006;14(Suppl1):41S–9S. doi:10.1038/oby.2006.281
   PubMedGoogle Scholar
• Kota SK, Kota SK, Jammula S, Panda S, Modi KD. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications. Diabetes Technol Ther. 2011;13(11):1155–1160. doi:10.1089/dia.2011.0120
   PubMedGoogle Scholar
• van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45(2):279–293. doi:10.1016/S0008-6363(99)00263-1
   PubMedGoogle Scholar